Absence of cellular responses to a putative autoantigen in onchocercal chorioretinopathy: Cellular autoimmunity in onchocercal chorioretinopathy

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 2, 1996, Pages 405-412

  Cooper, Philip J ^a,b,c   Guderian, Ronald H ^a   Proaño, Roberto ^a   Taylor, David W ^b  

^a HOSPITAL VOZANDES   (Ecuador)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Autoimmunity; Chorioretinopathy; Ecuador; Filariasis; Onchocerciasis

Indexed keywords

PARASITE ANTIGEN;

ADULT; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CHORIORETINOPATHY; CONTROLLED STUDY; DIAGNOSIS; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; MALE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, HELMINTH; AUTOANTIGENS; AUTOIMMUNITY; CHOROID DISEASES; CYTOKINES; ECUADOR; FEMALE; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MITOGENS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS, OCULAR; PREVALENCE; RETINAL DISEASES; T-LYMPHOCYTES;

EID: 0030023772     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. World Health Organisation Expert Committee on Onchocerciasis. Third report. Technical Report Series. 1987;752.
2. Thylefors B. Ocular onchocerciasis. Bull WHO. 1978;56:63-78.
3. Semba RD, Murphy RP, Newland HS, Awadzi K, Greene BM, Taylor HR. Longitudinal study of lesions of the posterior segment in onchocerciasis. Ophthalmology. 1990;97:1334-1341.
4. Newland HS, White AT, Greene BM, Murphy RP, Taylor HR. Ocular manifestations of onchocerciasis in a rain forest area of West Africa. Br J Ophthalmol. 1991;75:163-169.
5. Abiose A, Murdoch I, Babalola O, et al. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Br J Ophthalmol. 1994;78:8-13.
6. Rodger FC. The pathogenesis and pathology of ocular onchocerciasis: IV: The Pathology. Am J Ophthalmol. 1960;49:560-594.
7. Neumann E, Gunders AE. Pathogenesis of the posterior segment lesion of ocular onchocerciasis. Am J Ophthalmol. 1973;75:82-89.
8. John T, Barsky H, Donnelly JJ, Rockey JH. Retinal pigment epitheliopathy and neuroretinal degeneration in ascarid-infected eyes. Invest Ophthalmol Vis Sci. 1986;28:1583-1598.
9. Semba RD, Donnelly JJ, Young E, Green WR, Scott AL, Taylor HR. Experimental ocular onchocerciasis in cynomolgus monkeys: IV: Chorioretinitis elicited by Onchocerca volvulus microfilariae. Invest Ophthalmol Vis Sci. 1991;32.1499-1507.
10. Greene BM, Taylor HR, Brown EJ, Humphrey RL, Lawley TJ. Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes. J Infect Dis. 1983;147:890-897.
11. Bryant J. Endemic retino-choroiditis in the Anglo-Egyptian and its possible relationship to Onchocerca volvulus. Trans R Soc Trop Med Hyg. 1935;28:523-532.
12. Garner A, Duke BOL. Fundus lesions in the rabbit eye following inoculation of Onchocerca volvulus microfilariae into the posterior segment. Trop Med Parasitol. 1976;27:19-29.
13. Vingtain P, Thillaye B, Karpouzas I, Faure JP. Longitudinal study of microfilarial infestation and humoral immune response to filarial and retinal antigens in onchocerciasis patients treated with ivermectin. Ophthalmic Res. 1988;20:95. Abstract.
14. Van der Lelij A, Doekes G, Hwan BS, et al. Humoral autoimmune response against S-antigen and IRBP in ocular onchocerciasis. Invest Ophthalmol Vis Sci. 1990;31:1374-1380.
15. Braun G, McKechnie NM, Connor V, et al. Immunological crossreactivity between a cloned antigen of Onchocerca volvulus and a component of the retinal pigment epithelium. J Exp Med. 1991;174:169-177.
16. McKechnie NM, Braun G, Connor V, et al. Immunologic cross-reactivity in the pathogenesis of ocular onchocerciasis. Invest Ophthalmol Vis Sci. 1993;34:2888-2902.
17. Anderson J, Fuglsang H, Marshall TF de C, Radolowicz A, Vaughan JP. Studies on onchocerciasis in the United Cameroon Republic: IV: A four-year follow-up of six rain-forest and six savanna villages. The incidence of ocular lesions. Trans R Soc Trop Med Hyg. 1978;72:513-515.
18. McMahon JE, Sowa SIC, Maude GH, Kirkwood BR. Onchocerciasis in Sierra Leone 3: Relationships between eye lesions and microfilarial prevalence and intensity. Trans R Soc Trop Med Hyg. 1988;82:601-605.
19. Dadzie KY, Remme J, Rolland A, Thylefors B. Ocular onchocerciasis and intensity of infection in the community. 11. West African rain forest foci of the vector Simulium yahense. Trop Med Parasitol. 1989;40:348-354.
20. Dadzie KY, Remme J, Baker RHA, Rolland A, Thylefors B. Ocular onchocerciasis and intensity of infection in the community. 111. West African rain forest foci of the vector Simulium sanctipauli. Trop Med Parasitol. 1990;41:376-382.
21. Remme J, Dadzie KY, Rolland A, Thylefors B. Ocular onchocerciasis and intensity of infection in the community. 1. West African savanna. Trop Med Parasitol. 1989;40:340-347.
22. Anderson J, Fuglsang H, Marshall TF de C. Effects of diethylcarbamazine on ocular onchocerciasis. Tropenmed Parasitol. 1976;27:263-278.
23. Anderson J, Fuglsang H, Marshall TF de C. Effects of suramin on ocular onchocerciasis. Tropenmed Parasitol. 1976;27:279-296.
24. Bird AC, El Sheikh H, Anderson J, Fuglsang H. Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. Br J Ophthalmol. 1980;64:191-200.
25. Dadzie KY, Remme J, De Sole G. Epidemiological impact of vector control: II: Changes in ocular onchocerciasis. Acta Leidensa. 1990;59:127-139.
26. Dadzie KY, Remme J, Alley ES, de Sole G. Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus. Trans R Soc Trop Med Hyg. 1990;84:103-108.
27. Rothova A, Van der Lelij A, Stilma JS, Klaassen-Broekema N, Wilson WR, Barbe RF. Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin. Am J Ophthalmol. 1990; 110:6-16.
28. World Health Organisation. The effect of repeated ivermectin treatment on ocular onchocerciasis: Report of an informal consultation. TDR/TDE/ONCHO. 1993;4-5.
29. Chan CC, Nussenblatt RB, Kim MK, Palestine AG, Awadzi K, Ottesen EA. Immunopathology of ocular onchocerciasis 2: Anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology. 1987;94:439-443.
30. Zhou Y, Dziak E, Unnasch TR, Opas M. Major retinal cell components recognised by onchocerciasis sera are associated with the cell surface and nucleoli. Invest Ophthalmol Vis Sci. 1994;355:1089-1099.
31. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell. 1987;50:819-820.
32. Caspi RR, Roberge FG, McAllister CG, et al. T cell line mediating experimental autoimmune uveoretinitis (EAU) in rats. J Jmmunol. 1986;136:928-933.
33. Caspi RR. Basic mechanisms in immune-mediated uveitic disease. In: Lightman S, ed. Immunology of Eye Diseases. Amsterdam: Kluwer Academic Publishers; 1989:61-86.
34. Lightman SL, Chan CC. Immunopathology of ocular inflammatory disorders. In: Lightman S, ed. Immunology of Eye Diseases. Amsterdam: Kluwer Academic Publishers; 1989:87-99.
35. Detrick B, Hooks JJ. Autoimmune aspects of ocular disease. In: Rose NR, ed. The autoimmune diseases II. London: Academic Press; 1992;345-361.
36. Forrester JV. New concepts on the role of autoimmunity in the pathogenesis of uveitis. Eye. 1992;6:433-446.
37. Guderian RH, Leon LA, Leon R, Corral F, Vasconez C, Johnston TS. Report on a focus of onchocerciasis of Esmeraldas province of Ecuador. Am J Trop Med Hyg. 1982;31:270-274.
38. Cooper PJ, Proaño R, Beltran C, Anselmi M, Guderian RH. Onchocerciasis in Ecuador: Ocular findings in Onchocerca volvulus infected individuals. Br J Ophthalmol. 1995;79:157-162.
39. Steel C, Lujan-Trangay A, Gonzalez-Peralta C, ZeaFlores G, Nutman TB. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis. J Infect Dis. 1994;170:962-970.
40. Altman DG. Practical statistics for medical research. London: Chapman and Hall; 1991:210-212.
41. Bird AC, Anderson J, Fuglsang H. Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol. 1976;60:2-20.
42. Nussenblatt RB, Mittal KK, Ryan S, Green WR, Maumenee AE. Birdshot retinochoroidopathy: An association with HLA-A29 and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 1982;94:147-158.
43. Doekes G, Van der Gaag R, Rothova A, et al. Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res. 1987;7:909-919.
44. De Smet MD, Mochizuki M, Gery I, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol. 1991;110:135-142.
45. Gregerson DS, Abrahams IW, Thirkill CE. Serum antibody levels of uveitis patients to bovine retinal antigens. Invest Ophthalmol Vis Sci. 1981;21:669-680.
46. Abrahams IW, Gregerson DS. Longitudinal study of serum antibody responses to bovine retinal S-antigen in endogenous granulomatous uveitis. Br J Ophthalmol. 1983;67:681-684.
47. Van der Lelij A, Rothova A, Stilma JS, Hoekzema R, Kijlstra A. Cell-mediated immunity against human retinal extract, S-antigen, and interphotoreceptor retinoid-binding protein in onchocercal chorioretinopathy. Invest Ophthalmol Vis Sci. 1990;31:2031-3036.
48. Meilof JF, Van der Lelij A, Rokeach LA, Hoch SO, Smeenk RJT. Autoimmunity and filariasis: Autoantibodies against cytoplasmic cellular proteins in sera of patients with onchocerciasis. J Immunol. 1993; 151:5800-5809.
49. Rokeach LA, Zimmerman PA, Unnasch TR. Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognised by sera from patients with onchocerciasis. Infect Immun. 1994;62:3696-3704.
50. Petralanda I, Piessens WF. Pathogenesis of onchocercal dermatitis: Possible role of parasite proteases and autoantibodies to extracellular matrix proteins. Exp Parasitol. 1994;79:177-186.
51. Kawabata M, Flores GZ, Izui S, Kobayakawa T. IgM rheumatoid factors in Guatemalan onchocerciasis. Trans R Soc Trop Med Hyg. 1984;78:356-358.
52. Greenwood BM, Whittle HC. Immunology of Medicine in the Tropics. London: Edward Arnold; 1981:56-58.
53. Greenwood BM, Herrick EM, Holborow ET. Speckled antinuclear factor in African sera. Clin Exp Immunol. 1970;7:75-83.
54. Thomas MAB, Frampton G, Isenberg DA, Shoenfeld Y, Akinsola A, Ramzy M. A common anti-DNA antibody idiotype and antiphospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. J Autoimmunity. 1989;2:803-811.
55. Adebajo AO, Charles P, Maini RN, Hazleman BL. Autoantibodies in malaria, tuberculosis and hepatitis B in a West African population. Clin Exp Immunol. 1993;92:73-76.
56. Kobayakawa T, Loius J, Izui S, Lambert PH. Autoimmune response to DNA, red blood cells and thymocyte antigens in association with polyclonal antibody synthesis during experimental African trypanosomiasis. J Immunol. 1979;122:296-301.
57. Terry RJ, Hudson KM, Faghihi-Shirazi M. Polyclonal activation by parasites. In: Van den Bossche H, ed. The host-invader interplay. Proceedings 3rd International Symposium Biochemistry Parasites and Host-Parasite Relationships. Amsterdam: Elsevier; 1980:259-271.
58. Rocken M, Shevach EM. Do parasitic infections break T-cell tolerance and trigger autoimmune disease. Parasitol Today. 1993;9:377-380.
59. Tomer Y, Shoenfeld Y. The significance of natural autoantibodies. Immunol Invest. 1988;17:389-424.
60. Murphy RP, Taylor H, Greene BM. Chorioretinal damage in onchocerciasis. Am J Ophthalmol. 1984;98:519-520.
61. Taylor HR, Murphy RP, Newland HS, et al. Treatment of onchocerciasis: The ocular effects of ivemiectin and diethylcarbamazine. Arch Ophthalmol. 1986;104:863-870.